0920-1335 After Action Report - Simulated Voyage

Phased Approach to the Resumption of Cruise Ship Passenger Operations

Attachment V_Simulated Voyage After-Action Report Template

Cruise Ship Operator - After Action Report - Simulated Voyage

OMB: 0920-1335

Document [pdf]
Download: pdf | pdf
Conditional Sail Order Simulated Voyage
After-Action Report Template
Instructions
As per the terms of CDC’s Temporary Extension & Modification of Framework for Conditional Sailing Order
(CSO), cruise ship operators must conduct at least one simulated voyage as a condition of receiving
controlled free pratique for restricted passenger voyages under a COVID-19 Conditional Sailing Certificate. A
simulated voyage must be designed and conducted insofar as practicable to test the efficacy of the cruise
ship operator’s ability to mitigate the risk of COVID-19 onboard a cruise ship. The cruise ship operator must
document any deficiencies in its health and safety protocols through this “after-action” report and describe
how the cruise ship operator intends to address those deficiencies prior to applying for a COVID-19
Conditional Sailing Certificate. The after-action report must be submitted to the CDC as soon as practicable
at the end of the simulation and as part of the cruise ship operator’s application for a COVID-19 Conditional
Sailing Certificate. Where appropriate, incorporate into the after-action report photographic, video,
testimonial, or other evidence documenting that the simulated voyage was conducted in accordance with
the cruise ship operator’s health and safety protocols and CDC’s technical instructions.
Cruise Ship Operator and Ship Information
Name of Cruise Ship Operator:
Name of Cruise Ship:
Dates of Simulated Voyage (including number of days and overnight stays):
Port of Embarkation/Debarkation:
Itinerary:

Simulated Activity # 1: Terminal Check-in

1.

Description
of Simulated
Activity

Simulated Voyage After-Action Report

Strengths

Areas for
Improvement
Corrective
Actions
Simulated Activity # 2: Embarkation
Description
of Simulated
Activity
Strengths
2.
Areas for
Improvement
Corrective
Actions
Simulated Activity # 3: Disembarkation
Description
of Simulated
Activity
3.

Strengths

Areas for
Improvement

Page 2 of 8

Simulated Voyage After-Action Report

Corrective
Actions
Simulated Activity # 4: Onboard Activities
Description
of Simulated
Activity
Strengths
4.

Areas for
Improvement
Corrective
Actions
Simulated Activity # 5: Evacuation
Description
of Simulated
Activity
Strengths
5.

Areas for
Improvement
Corrective
Actions
Simulated Activity # 6: Transfer of Travelers Who Are Symptomatic or Test Positive for SARS-CoV-2
6.

Description
of Simulated
Activity

Page 3 of 8

Simulated Voyage After-Action Report

Strengths

Areas for
Improvement
Corrective
Actions
Simulated Activity # 7: Onboard Isolation and Quarantine
Description
of Simulated
Activity
Strengths
7.

Areas for
Improvement
Corrective
Actions
Simulated Activity # 8: Shoreside Isolation and Quarantine
Description
of Simulated
Activity
Strengths
8.

Areas for
Improvement
Corrective
Actions
Page 4 of 8

Simulated Voyage After-Action Report

Simulated Activity # 9: Recreational Activities
Description
of Simulated
Activity
Strengths
9.

Areas for
Improvement
Corrective
Actions
Simulated Activity # 10: Private-island Shore Excursions
Description
of Simulated
Activity
Strengths
10.

Areas for
Improvement
Corrective
Actions
Simulated Activity # 11: Ports of Call Shore Excursions

11.

Description
of Simulated
Activity
Strengths

Page 5 of 8

Simulated Voyage After-Action Report

Areas for
Improvement
Corrective
Actions
Additional Simulated Activities (Attach Additional Sheets as Necessary)
Description
of Simulated
Activity
Strengths
12.

Areas for
Improvement
Corrective
Actions
Post-disembarkation Test Results

13.

☐

By checking this box, I confirm that at least 75% of all passengers have provided a
specimen collected 3 to 5 days after disembarkation to the cruise ship operator’s
selected laboratory for COVID-19 testing. CDC may lower the 75% postdisembarkation testing requirement for future simulated voyages based on lessons
learned from previous simulated voyages and other factors. I further confirm that
all aggregate post-disembarkation test results are included in the after-action
report to CDC or if any post-disembarkation test results are received after the
submission of this report that an amended report will be submitted to CDC.

Overall Assessment of Health and Safety Protocols

14.

In this section, include the cruise ship operator’s overall assessment and conclusions regarding the
efficacy of its health and safety protocols at mitigating the risk of COVID-19 onboard the cruise ship
and whether any changes, modifications, or adjustments to these protocols will occur based on
“lessons learned” from the simulated voyage.

Page 6 of 8

Simulated Voyage After-Action Report

Best Practices and Lessons Learned from Voyages Outside of U.S. (if applicable)
Description of best practices and lessons learned from voyages that occurred outside of the U.S.
(attach additional sheets as needed).

15.

Certification Statement

Page 7 of 8

Simulated Voyage After-Action Report

I hereby certify that the information submitted in this after-action report is complete and accurate to the
best of my knowledge and belief. This after-action report is submitted in fulfillment of CDC’s requirements
for conducting a simulated voyage and as a condition of obtaining a COVID-19 Conditional Sailing
Certificate. Based on CDC’s review of the after-action report, CDC may require that the cruise ship
operator modify its practices or procedures and/or engage in additional simulated voyages prior to the
issuance of the COVID-19 Conditional Sailing Certificate. I acknowledge that any false or misleading
statements or omissions in this after-action report may endanger health and safety, including but not
limited to the loss of lives and other irreparable harm.
Chief Executive Officer (or Equivalent) of Operating Company
Last name:
First name:

Middle initial:

Signature:

Date:

Chief Compliance Officer (or Equivalent) of Operating Company
Last name:
First name:

Middle initial:

Signature:

Date:

Highest-Ranking Medical Officer of Operating Company
Last name:
First name:

Middle initial:

Signature:

Date:

Chief Executive Officer (or Equivalent) of Parent Company
Last name:
First name:

Middle initial:

Signature:

Date:

Chief Compliance Officer (or Equivalent) of Parent Company
Last name:
First name:

Middle initial:

Signature:

Date:

Highest-Ranking Medical Officer of Parent Company
Last name:
First name:

Middle initial:

Signature:

Date:

For official use only:

Page 8 of 8


File Typeapplication/pdf
AuthorStefanie White
File Modified2021-10-18
File Created2021-10-17

© 2024 OMB.report | Privacy Policy